Nigeria has written the policy that would move depression treatment into primary care. What it has not done, in most states, is pay for the screening, the drugs and the supervision that make the policy real. The result is a treatment gap that opens at first contact and widens from there. This piece looks at where the gate holds and what programme designers can move.

The Treatment Gap at First Contact

A patient with persistent low mood, sleeplessness and weight loss usually arrives at a primary health centre, not a psychiatric hospital. The nurse on duty may record the physical complaints and treat them one at a time. Depression itself often goes unnamed, because no one in the room has been trained to ask, and no form on the desk invites the question.

Specialist capacity is concentrated in a handful of urban teaching hospitals. Psychiatrists, clinical psychologists and psychiatric nurses cluster where the medical schools are, leaving large rural districts with no specialist at all. Referral from a village clinic to a psychiatrist can mean a journey of several hours and a fee the household has not budgeted for.

Nigeria's mental health policy documents have favoured integration into primary care for years, and the National Primary Health Care Development Agency (NPHCDA) oversees a large network of primary facilities meant to carry that load. The documents describe the model well. The distance between the document and the consulting room is where most of the problem sits.

It helps to be concrete about what first contact looks like. A woman who has stopped sleeping and has begun to lose weight will often be seen three or four times before anyone writes a word about mood. She may be treated for malaria, then for a presumed ulcer, then sent home with an antimalarial and a vitamin. Each visit consumes a clinic card, a queue number and a small payment. The cumulative cost of not naming the problem is borne entirely by the household, and it is not small.

What the Policy Promises

The integration model rests on task-sharing: training general nurses and community health extension workers to screen for depression, deliver brief psychological support and manage uncomplicated cases with supervision from a distant specialist. Where task-sharing has been tried in low-resource settings, it has usually worked better than critics predicted, provided supervision is real and not a signature on a monthly return.

Funding is the weak joint. Training budgets are uneven across states, and refresher training depends on donor cycles rather than on a line in the state health budget. A nurse trained in 2019 may have had no structured supervision since, which matters because screening without a working referral pathway produces identified patients and nowhere to send them.

The referral chain is meant to run from the primary clinic to a district psychiatric unit and onward to a tertiary centre. In practice the district tier is thin. A clinic that screens positive and finds no functioning district unit learns quickly that screening creates problems it cannot solve, and the forms go back in the drawer.

There is also a staffing arithmetic that policy documents tend to skip. A community health extension worker may be responsible for a catchment of several thousand people, with antenatal visits, immunisation days and childhood illness absorbing most of the working week. Adding a fifteen-minute depression screen to every adult consultation is not a small marginal ask. It is a reallocation of a scarce clinical hour, and someone has to decide what gets displaced.

Payer Rules and Out-of-Pocket Costs

Mental health sits at the edge of Nigeria's health financing arrangements. Coverage under the national health insurance scheme has historically leaned toward physical conditions, and mental health benefits have been limited or unclear depending on the plan. For most households, the cost of antidepressants is paid at the pharmacy counter, in full, at prices that compete with food.That cost structure shapes who presents and when. A patient who cannot afford a month of medication may take it for two weeks, feel better, stop, and relapse. Others delay the first visit entirely, arriving only when functioning has collapsed and a family member intervenes. The pattern is familiar from other chronic conditions in the region; this site has described similar late presentation in hypertension care in Brazil's Northeast, where diagnosis follows the stroke rather than preceding it.

Cash-based payment also distorts the clinical conversation. A nurse who knows the patient cannot buy the drug may soften the diagnosis to avoid prescribing something unaffordable. That is a rational response to a broken benefit package, and it leaves the true prevalence of treated depression invisible in the records.

Supply adds a second layer. Even where a facility is authorised to dispense a basic antidepressant, stock-outs are common, and a patient who is told to return next month may not. Continuity of a daily medication depends on a supply chain that reaches the last clinic, and mental health commodities are rarely given priority in that chain. A prescription written and never filled is a clinical decision that quietly evaporates.

Why Screening Tools Sit on Shelves

Brief screening instruments suitable for primary care exist and have been validated in Nigerian populations. They take a few minutes and need no laboratory. The barrier is not the tool. It is the consultation time, the queue outside the door, and the absence of a supervisor who will review a positive screen and advise on next steps.

Stigma shapes disclosure as much as it shapes diagnosis. A patient in a shared waiting area may not describe hopelessness to a nurse who lives in the same community, and the clinic layout rarely offers privacy. Screening questions asked in an open room produce polite negatives.

There is a real trade-off in adding depression screening to an already overloaded clinic day. A nurse who spends ten extra minutes on a mental health screen sees fewer children for immunisation, and the clinic's monthly indicators punish that. Until the indicator set rewards the work, screening will lose to the queue every time.

Language matters here too. Screening instruments developed and validated in one language do not automatically carry their meaning into another, and a question about hopelessness translated literally can land as a question about bad luck. Adapting and re-testing an instrument for local idiom is unglamorous work that rarely appears in a training budget, yet it determines whether the tool measures what it claims to measure.

Equity Gaps Between States and Households

Service coverage varies sharply by state, and the variation tracks budget priority more than need. Some states have invested in mental health focal persons and training; others have not. Rural clinics are the most exposed, with fewer trained staff and longer referral distances, while urban centres hold most of the psychiatrist workforce.

Household-level inequity cuts across that geography. Women carrying caregiving and income responsibilities often cannot spare a clinic day, and low-income patients face the full out-of-pocket price. A related piece on atrial fibrillation screening in rural Kerala makes a comparable point about screening programmes that find conditions the system cannot then treat.

Data gaps make the picture harder to act on. Facility-level reporting on depression screening and treatment is patchy, and mental health spending is rarely separated out in state budget lines. Without that separation, a state can claim commitment to integration while its actual expenditure says otherwise.

The consequence is that advocacy has to argue from anecdote rather than from a count. A state health commissioner asking how many people were treated for depression last year may genuinely not be able to find out, and a figure that cannot be produced cannot be defended in a budget meeting. Counting is not a bureaucratic ritual here; it is the precondition for a claim on resources.

Practical Steps for Programme Designers

Fund routine depression screening at primary care level through a dedicated budget line, and tie the funding to supervision rather than to a one-off training workshop.

Add a defined mental health benefit to insurance packages, including at least a basic antidepressant formulary, so prescribing decisions stop depending on the patient's cash at the counter.

Train and supervise primary care nurses in task-sharing, with scheduled case review by a district psychiatric focal person and protected time in the clinic day for the work.

Publish facility-level service and spending data, disaggregated by state and by rural or urban location, so that gaps become visible to the people who allocate budgets.

Build formal referral links from primary clinics to district psychiatric units, with a named contact and a defined response time, before screening is scaled up.

Sequence the work honestly. Screening should follow, not precede, a functioning supply of medication and a reachable supervisor. A programme that reverses that order generates waiting lists for a service that does not exist, and the patients it identifies are the ones who pay for the mistake.

This article is informational and does not constitute personalised medical or policy advice. Programme decisions should rest on local data and qualified clinical input.